| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 19, 2025 | Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities | Getting your Trinity Audio player ready...
By Melba Newsome, KFF Health News
For more than a year, Diane Hunter, now 72, had been experiencing vague symptoms — pain in her spine and hips, nausea, exhaustion, thirst, and frequent urination. ... |
| Aug 6, 2025 | FDA approves expanded indication for AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation in cytokine release syndrome (CRS) | Approval of AVTOZMA® (tocilizumab-anoh) intravenous infusion expands label to include treatment of adults and pediatric patients aged 2 years and older with cytokine release syndrome (CRS) [1]
AVTOMZA received FDA approval in January 2025, ... |
| Nov 19, 2024 | Healing Through Innovation: The Future of Multiple Myeloma Treatment | Multiple myeloma is a formidable foe. It lurks in the shadows, often unnoticed until it strikes with debilitating symptoms. For many, like Patricia Wong, the journey begins with pain—severe back pain that disrupts life. This pain, a siren c... |
| Nov 19, 2024 | Recent breakthroughs expand treatment options for multiple myeloma | Listen to this article
Recent breakthroughs expand treatment options for multiple myeloma
1 min
New: You can now listen to articles.
This audio is generated by an AI tool.
In 2022, Ms Patricia Wong’s life was disrupted when severe back pain... |
| Aug 29, 2024 | The International Myeloma Foundation (IMF) Brings Back ‘Do You #kNOwMyeloma?’ for Blood Cancer Awareness Month 2024 | LOS ANGELES, Aug. 29, 2024 (GLOBE NEWSWIRE) -- With Blood Cancer Awareness Month coming up this September, the International Myeloma Foundation (IMF) is reviving and amplifying its highly successful #kNOwMyeloma campaign, centering on the q... |
| Apr 22, 2024 | LatentView Analytics Receives 'Partner of the Year Award' at the International Myeloma Foundation's 15th Annual Gala | LatentView Analytics
LatentView Analytics CEO Rajan Sethuraman accepts the distinguished award at IMF event in New York City that benefits the Peter Boyle Research Fund
PRINCETON, N.J., April 22, 2024 /PRNewswire-PRWeb/ -- LatentView Analyt... |
| Aug 11, 2023 | Antengene Enters into Commercialization Partnership with Hansoh Pharma for First/Only-in-Class XPO1 Inhibitor XPOVIO®(selinexor) in the Mainland of China | - Antengene and Hansoh Pharma to enter into collaboration agreement involving commercialization of XPOVIO® in the mainland of China, broadening coverage and improving access of the drug to patients in the mainland of China
- Antengene to re... |
| Jul 26, 2023 | The International Myeloma Looks to LatentView Analytics to Improve Patient Care and Outcomes through the Power of Data | LatentView Analytics We are proud to be at the forefront of using data analytics to advance the IMF’s mission and aid in the fight against multiple myeloma.
PRINCETON, N.J. (PRWEB) July 26, 2023
LatentView Analytics, a global digital analyt... |
| Jul 18, 2023 | HMP Global announces International Myeloma Foundation (IMF) as partner with Lymphoma, Leukemia & Myeloma Congress (LL&M) | LL&M is the meeting where interdisciplinary specialists convene to explore the controversial and complex world of blood cancer through debate, discussion, and networking.
MALVERN, Pa (PRWEB) July 18, 2023
HMP Global, the leading omnicha... |
| Jul 17, 2023 | Antengene Announces XPOVIO® Regulatory Approval in Hong Kong for the Treatment of Relapsed and/or Refractory Multiple Myeloma | XPOVIO® (selinexor) is the first and only XPO1 inhibitor approved in Hong Kong
XPOVIO® has received regulatory approvals in 41 countries and regions including the United States, Israel, the United Kingdom, the European Union (the 27 member ... |
| Feb 23, 2023 | International Myeloma Foundation (IMF) Launches #MYelomaSTORY Campaign for Myeloma Action Month in March 2023 | STUDIO CITY, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- With the International Myeloma Foundation (IMF) at the forefront, Myeloma Action Month is held every year for the whole month of March to encourage individuals and groups to take action... |
| Feb 23, 2023 | International Myeloma Foundation (IMF) Launches #MYelomaSTORY Campaign for Myeloma Action Month in March 2023 | /EIN News/ -- STUDIO CITY, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- With the International Myeloma Foundation (IMF) at the forefront, Myeloma Action Month is held every year for the whole month of March to encourage individuals and groups ... |
| May 18, 2022 | Antengene Announces XPOVIO® Treatment Regimens Included for the First Time in the Guidelines for the Diagnosis and Management of Multiple Myeloma in China | SHANGHAI and HONG KONG, May 18, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and comme... |
| May 13, 2022 | Antengene Announces XPOVIO® (selinexor) Data to be Presented at the Upcoming 2022 European Hematology Association Hybrid Congress | SHANGHAI and HONG KONG, May 13, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and comme... |
| Apr 6, 2022 | Antengene's Pivotal "MARCH" Study to Evaluate Selinexor (ATG-010) in Relapsed or Refractory Multiple Myeloma Published in BMC Medicine | - Results showed an overall response rate (ORR) of 29.3% for all treated patients.
- Consistent responses across all risk groups, including patients who received prior "triple-class" and CAR-T therapies or having cytogenetic abnor... |
| Sep 9, 2021 | International Myeloma Foundation : Congratulates Board Member Dr. S. Vincent Rajkumar on Receiving the Prestigious Waldenström Award for Outstanding Research | LOS ANGELES, Sept. 9, 2021 /PRNewswire/ -- International Myeloma Foundation Board Member Dr. S. Vincent Rajkumar, professor of medicine at the Mayo Clinic, was recognized Wednesday for his outstanding contribution to myeloma research by the... |
| Sep 9, 2021 | International Myeloma Foundation Congratulates Board Member Dr. S. Vincent Rajkumar on Receiving the Prestigious Waldenström Award for Outstanding Research | |
| Sep 9, 2021 | International Myeloma Foundation Launches Baltimore-Area Campaign to Raise Disease Awareness and Improve Outcomes in the African-American Community | |
| Aug 26, 2021 | The International Myeloma Foundation (IMF) Highlights Blood Cancer Awareness Month with the "Do You Know Myeloma?" Campaign | LOS ANGELES, Aug. 26, 2021 /PRNewswire/ -- This September, the International Myeloma Foundation (IMF) will take part in Blood Cancer Awareness Month (BCAM). The global initiative focuses on all blood cancers, with myeloma ranking as the sec... |
| Aug 26, 2021 | The International Myeloma Foundation (IMF) Highlights Blood Cancer Awareness Month with the "Do You Know Myeloma?" Campaign | |
| Aug 19, 2021 | Man Who Loses Father to Multiple Myeloma Hikes 2,200 Miles to Support Research to Find a Cure | |
| Jun 15, 2021 | International Myeloma Working Group to Honor Dr. Nikhil Munshi, Dr. Shaji Kumar for Exceptional Achievements at 12th Annual IMWG Summit on June 23rd | |
| May 19, 2021 | With 80,000 Participants, the Largest Study of Its Kind Is the First to Evaluate the Benefits of Screening for a Precursor to the Blood Cancer Multiple Myeloma | |
| Apr 6, 2021 | The International Myeloma Foundation (IMF) Sparks a Season for Change with the Most Impactful Myeloma Action Month Ever | |
| Mar 29, 2021 | International Myeloma Foundation Says FDA Approval of Bristol Myers Squibb's and bluebird bio's CAR T-Cell Immunotherapy Treatment for Multiple Myeloma Is Welcome News for Patients | |
| Mar 11, 2021 | International Myeloma Foundation Launches "M-Power Charlotte" to Improve Outcomes in Multiple Myeloma, a Cancer That Disproportionately Affects African Americans | |
| Feb 25, 2021 | International Myeloma Foundation (IMF) Launches 31 Days of Resilience Campaign for Myeloma Action Month in March 2021 | |
| Oct 27, 2020 | The International Myeloma Working Group (IMWG) New Risk Stratification Model for Smoldering Myeloma Will Reduce Risk of Disease Progression and End-Organ Damage | |
| Oct 22, 2020 | International Myeloma Foundation 14th Annual Comedy Celebration Goes Virtual In 2020, Featuring "Everybody Loves Raymond" Cast Reunion Hosted By Ray Romano On October 23 At 9 PM ET | |
| Janssen Oncology: Inspired by its mission to Reimagine care. Redefine living. | Serge Messerlian, US President, Janssen Oncology, and Imran Khan, MD, PhD, Vice President, US Hematology Medical Affairs, connected to discuss how the organization’s mission to Reimagine care. Redefine living. inspires them at the American ... |
| Communication Is Key When Facing a Multiple Myeloma Diagnosis | (BPT) - Sanofi developed and sponsored this article and Roldan was compensated for his time.
As an avid runner, Roldan enjoyed an active lifestyle. However, during a routine physical one decade ago, his physician observed an abnormal elevat... |